Equities

Pegavision Corp

6491:TAI

Pegavision Corp

Actions
Health CareMedical Equipment and Services
  • Price (TWD)426.00
  • Today's Change-10.50 / -2.41%
  • Shares traded1.13m
  • 1 Year change+13.00%
  • Beta--
Data delayed at least 20 minutes, as of Jul 30 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pegavision Corp is primarily engaged in the manufacture and sale of private brand contact lenses, as well as the original equipment manufacturing (OEM) business. The Company distributes its products within domestic market and to overseas markets.

  • Revenue in TWD (TTM)7.06bn
  • Net income in TWD1.83bn
  • Incorporated2009
  • Employees589.00
  • Location
    Pegavision Corp2F.-1No.5, Shing Yeh St., Shanding VillageTAOYUAN 333TaiwanTWN
  • Phone+886 33298808
  • Fax+886 33298897
  • Websitehttps://www.pegavision.com/tw/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
6491:TAI since
announced
Transaction
value
Pegatron Corp - AssetsAnnounced21 Sep 202321 Sep 2023Announced16.39%94.88m
Data delayed at least 20 minutes, as of Jul 30 2024.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SciVision Biotech Inc787.96m196.83m7.27bn64.0039.824.7027.969.232.672.6710.3322.670.36012.148.34--9.006.6710.097.4174.1369.9424.9825.002.90--0.173979.7427.9316.6925.5315.41-31.1611.38
CHC Healthcare Group3.73bn341.88m7.79bn160.0025.171.268.442.091.861.8619.9736.920.27534.083.97--2.523.233.003.8026.3730.129.1513.162.0110.780.45581.7530.359.1117.475.319.692.25
Excelsior Medical Co Ltd8.27bn729.96m13.82bn774.0019.001.6611.901.674.674.6752.9653.650.47065.365.48--5.144.9410.499.2520.2520.2210.9110.601.28--0.091483.2214.565.3511.8610.5831.537.24
Vizionfocus Inc2.83bn654.83m13.92bn--19.934.3513.254.9212.1412.1452.6055.630.64016.996.07--17.0312.0022.0016.5440.9037.0126.6020.522.90--0.279528.7340.2352.1879.65233.8971.42--
Taidoc Technology Corp4.35bn1.02bn15.50bn829.0015.191.6712.093.5710.7010.7045.4397.110.34681.953.98--8.5117.6011.7322.9840.6350.7324.5528.493.14--0.065968.99-50.072.03-69.933.02-34.714.58
Visco Vision Inc2.69bn432.93m16.10bn--37.245.3819.335.996.866.8642.6047.460.53972.855.99--8.5611.6811.1715.8039.4040.5615.8617.721.1621.320.270743.00-13.6825.82-51.158.740.8293--
Pegavision Corp7.06bn1.83bn34.05bn589.0018.133.5312.404.8324.0724.0793.55123.710.59055.158.98--15.4714.5721.9720.1255.2551.6426.1921.751.39--0.10533.677.4116.737.3825.07-5.9446.64
Data as of Jul 30 2024. Currency figures normalised to Pegavision Corp's reporting currency: Taiwan Dollar TWD

Institutional shareholders

6.83%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Jul 20241.64m2.10%
Norges Bank Investment Managementas of 31 Dec 20231.56m2.00%
Dimensional Fund Advisors LPas of 04 Jul 2024649.42k0.83%
BlackRock Fund Advisorsas of 04 Jul 2024383.42k0.49%
Causeway Capital Management LLCas of 30 Jun 2024318.00k0.41%
Schroder Investment Management (Hong Kong) Ltd.as of 31 Mar 2024273.60k0.35%
Fubon Asset Management Co., Ltd.as of 04 Jul 2024211.00k0.27%
BlackRock Advisors (UK) Ltd.as of 04 Jul 2024115.72k0.15%
JPMorgan Asset Management (Taiwan) Ltd.as of 31 Dec 202290.15k0.12%
Mellon Investments Corp.as of 03 Jul 202479.00k0.10%
More ▼
Data from 31 Dec 2023 - 26 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.